Regulation
Neutral
Injective CEO Forecasts US INJ ETF Launch Earlier Than 2027

Injective (INJ) co-founder and CEO Eric Chen said in a DoubleBlock interview that while he cannot specify an exact timeline for the U.S. INJ spot ETF launch, it will occur "much sooner than 2027." Current SEC filings include two applications: 21Shares' Injective ETF and Canary Staked INJ ETF, both of which submitted amended S-1 registration statements in September. Chen also noted that Injective is pursuing additional U.S. licenses, following the company's August acquisition of SEC registration as a transfer agent.
Korean Source
This article is an English localization of a Korean-language crypto news report. Original headline: 인젝티브 CEO "美 INJ ETF, 2027년보다 훨씬 앞서 출시 전망"